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Key Points 
 
1. Macrophages in the hindbrain-branchial arches region of the mouse embryo play a 
positive role in HS/PC expansion and/or maturation 
 
2. Macrophages from embryonic head hematopoietic niches produce pro-inflammatory 
factor TNFα and enhance HS/PC expansion and/or maturation 
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Abstract 
 
Along with the aorta-gonad-mesonephros region, the head is a site of hematopoietic stem 
and progenitor cell (HS/PC) development in the mouse embryo. Macrophages are present in 
both these embryonic hemogenic sites and recent studies indicate a functional interaction of 
macrophages with hematopoietic cells as they are generated in the aorta. Whereas, brain 
macrophages or ‘microglia’ are known to affect neuronal patterning and vascular circuitry in 
the embryonic brain, it is unknown whether macrophages play a role in head hematopoiesis. 
Here we characterize head macrophages and examine whether they affect the HS/PC 
output of the hindbrain-branchial arch (HBA) region of the mouse embryo. We show that 
HBA macrophages are CD45+F4/80+CD11b+Gr1- and express the macrophage-specific 
Csf1r-GFP reporter. In the HBA of chemokine receptor deficient (Cx3cr1-/-) embryos, a 
reduction in erythropoiesis is concomitant with a decrease in HBA macrophage percentages. 
In cocultures, we show that head macrophages boost HPC numbers from HBA endothelial 
cells >2-fold, and that the pro-inflammatory factor TNFα is produced by head macrophages 
and influences HBA hematopoiesis in vitro. Taken together, head macrophages play a 
positive role in HBA erythropoiesis and HS/PC expansion and/or maturation, acting as 
micro-environmental cellular regulators in hematopoietic development. 
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Introduction 
Hematopoietic stem cells (HSC) are the self-renewing source of mature blood cell lineages 
in the adult. During embryonic development both hematopoietic progenitor cells (HPC) and 
HSCs are generated from endothelial cells of the major vasculature (aorta and 
vitelline/umbilical arteries)1-4 through a specialized developmental process, endothelial-to-
hematopoietic-transition (EHT) and emerge in the lumen as cell clusters. The mouse 
embryonic head also generates HSCs and HPCs 5 and functional hematopoietic assays 
localize these cells to the hindbrain and branchial arch (HBA) 6 vascular regions. Rather than 
the formation of hematopoietic clusters as in the embryonic aorta lumen, imaging analyses 
of the HBA reveal the close associations of only single hematopoietic cells adjacent to 
endothelial cells6, suggesting differences in the regulation of head hematopoietic 
development.  
Molecular studies on hematopoietic stem/progenitor cell (HS/PC) development in the aorta 
of zebrafish embryos and the aorta-gonad-mesonephros (AGM) region of mouse embryos 
identified some factors and signalling pathways that facilitate EHT2,7-9. Investigations 
focusing on the cellular micro-environment surrounding the embryonic aorta10 revealed rare 
cell-cell interactions involving neutrophils11and macrophages12,13: In zebrafish embryos, 
neutrophils signal to the intra-aortic hematopoietic cells (IAHC) through TNF and 
macrophages promote HS/PC mobilization at the vascular wall through localized production 
of MMP2/912,13. A surprisingly large number of CD45+F4/80+ macrophages were found to be 
scattered around the mouse E10.5 aorta and adjacent to cells of the IAHC8,14-16. Recent 
time-lapse imaging studies show transient interactions of macrophages with IAHC 16.   
The earliest embryonic macrophages in the mouse are formed in the yolk sac blood islands 
beginning at E7.517. In vivo lineage tracing supports a recruitment of these macrophages to 
head region, where in the brain they become the tissue resident macrophages, ‘microglia’ 
that persist through all stages of life18,19. Microglia are regulators of central neural system 
patterning and promote vascular networking during embryonic stages20-22. During adult 
stages, macrophages are effectors of immune response homeostasis (pro- and anti-
inflammatory). Macrophages express the transmembrane tyrosine kinase receptor (Csf1r)23 
and are regulated by colony stimulating factor-1 (Csf-1). Csf1r−/− mice exhibit diminished 
macrophage numbers, reproductive defects, obstructed organ development, and a severe 
brain phenotype (neocortical progenitor proliferation and apoptosis is increased, and the 
differentiation of some neuronal subtypes is reduced)24,25. While microglia-neuron 
interactions are thought to involve the Cx3cr1-Cx3cl1 chemokine signaling pathway26, it 
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remains unknown whether macrophages/microglia are regulators of embryonic head 
hematopoiesis. 
Pro-inflammatory factors produced by innate immune cells, such as Interleukin-1 (IL-1), 
interferons (IFN) and tumor necrosis factor α (TNFα) play a role in embryonic 
hematopoiesis27. In Zebrafish embryos, TNFα secreted by neutrophils activates downstream 
signalling pathways implicated in aortic HS/PC production11. IL1 receptor (IL-1RI)–deficient 
mouse embryos show a slight decrease in AGM HSC activity28 in mouse and zebrafish 
embryos deficient for IFN-γ or IFN-α are significantly reduced in HS/PCs15. In this study, we 
examine the role of head macrophages in HS/PC development in the mouse embryonic HBA 
and report that they influence HBA erythropoiesis and promote expansion and/or maturation 
of HBA HS/PC through TNFα arising from HBA macrophages. 
 
Materials and methods 
Mouse and embryo generation.  Wild type C57BL/6 and MacGreen (Csf1r-GFP)29, Cx3cr1-
GFP30, Csf1r-Cre31 (from J. W. Pollard), RosaDTAlox32 (from G. Kassiotis) and Vav-Cre 33 
(from N. Speck) mice (all C57BL/6-Ly5.2 background) were used for timed matings and 
C57BL/6-Ly5.1 mice (8-12 weeks) were transplantation recipients. Embryos were generated 
from MacGreen males crossed with wild type females, and Csf1r-Cre females crossed with 
RosaDTA males. Embryo staging was done by somite pair counts34. HBA were dissected 6 
(Fig.1A) and forebrains used for pheno/genotyping. PCR primers used for genotyping 
embryos are in SupTable 1. Mice were housed in the University of Edinburgh animal 
facilities and experimentation complied with UK Home Office Regulations and Licensing. 
Hematopoietic progenitor and stem cell assays.  Single-cell suspensions from HBA or 
cultures were seeded in the Methylcellulose (M3434; Stem Cell Technologies) colony-
forming unit-culture (CFU-C) assay, colonies counted after 10 days and lineage specific 
colony outputs quantitated as number of CFU-C per one embryo equivalent (ee) of HBA 
cells. HBA cells (1-3ee) were injected intravenously into (9.0Gy γ-irradiation, split dose) 
Ly5.1 mice. Peripheral blood was taken (4 and 16 wks) for Ly5.1-/Ly5.2-specific FACS 
analysis. Recipients are considered repopulated when ≥5% of cells are donor-derived.  
OP9-DL1 coculture system. OP9-DL1-B1 (Bmp4-/-) cells were generated by CRISPR-Cas9 
(Bmp4 exon1 sg (single guide) RNA: 5’-GTGTAAGGTTCGACGGACCG-3’, 
5’CGGTCCGTCGAACCTTACAC-3’; Bmp4 exon3 sgRNA: 5’-
ACCATCAGCATTCGGTTACC-3’, 5’-GGTAACCGAATGCTGATGGT-3’) engineering. HBA 
cells were cocultured in 10% FBS (Hyclone, Brunschwig Chemie), -MEM, 1%Pen-Strep, 
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1%Glutamax (all from Gibco) with OP9-DL1-B1 cells (SCF100ng/ml, IL3 100ng/ml and Flt3-
ligand 100ng/ml; PeproTech) +/- CSF1R Inhibitor (BLZ945 6.7nM diluted in DMSO, 
MedChemExpress) 35. TNF, IL1β (PeproTech), TNFneutralizing antibody 1μg/ml; R&D 
Systems) was added at the start of coculture. After 7 days, supernatant and semi-adhesive 
cells were harvested and sorted for ELISA assays and methylcellulose cultures, respectively.   
Flow cytometry. Cells from HBA, cultures and adult hematopoietic tissues were antibody-
stained (SupTable 2) for 30’ on ice. Sorted cells were collected in 50% FBS/PBS for 
functional analyses or in lysis buffer for RNA extraction. Cytometry was performed on 
BDFortessa /Aria‖ (BD Biosciences). 
Gene Expression Analysis. RNA from sorted cells was extracted with RNeasy MicroKit 
(Qiagen). cDNAs were generated with oligdT primers and SuperScriptIII Reverse 
Transcriptase (Thermo Fisher Scientific). RT-PCR were performed by using Fast SYBRTM 
Green Master Mix and ABI7900 (Thermo Fisher Scientific) detection. Primers are listed in 
SupTable 3.  
Embryo Immunostaining. Wholemount staining was performed according to published 
methods36. MacGreen embryonic head was fixed 20’ in 2% PFA. Antibodies are listed in 
SupTable 2. 
Cytokine assays. TNFα protein concentration was tested with the BDTM Cytometric Bead 
Array (CBA) Kit. Standard curves were generated using supplied control samples and data 
analysed by FCAPArrayTM software. 
Statistical Analyses.  Comparisons of 2 groups were performed with Student’s t-test and 
comparison of more than 2 groups were performed using One-way ANOVA test. p<0.05 was 
considered significant. 
 
Results 
Phenotypic characterization of macrophages in the mouse embryonic HBA.  The 
hindbrain branchial (first and second) arch (HBA) region from Csf1r-GFP (MacGreen, 
macrophage reporter) transgenic mouse embryos was dissected (Fig.1A) and cells analysed 
by flow cytometry19,24,29. Brain-resident macrophages, microglia, originate from E7.5 yolk sac 
myeloid precursors and upon entry into the brain lose cKit expression and initiate F4/80 
expression19,37. 99.6% of GFP+ cells in the E10 HBA were positive for the hematopoietic 
marker CD45 (Fig.1B). Whereas >95% of these cells were CD11b+F4/80+, only a small 
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percentage were CD11b+F4/80-. Both fractions were negative for the granulocytic marker 
Gr1. Likewise, almost all (99.2%) CD45+F4/80+CD11b+Gr1- cells were GFP+ (Sup.Fig.1A). 
Thus, most HBA GFP+ cells are macrophages. Between E9.5 and E10.5 there was a 
significant 3-fold increase in HBA GFP+ cells (0.29±0.02% and 0.93±0.08%, respectively) 
which further increased to 1.13±0.23% at E11.5 (Fig.1C). 
E10.5 MacGreen embryo wholemount images showed macrophages scattered throughout 
the HBA, with many macrophages localized around the CD31+ endothelial cells of the large 
lateral vessels (Fig.1D, 1Di), the carotid arteries 6,38. Macrophages also localized along the 
small vessels (not shown), consistent with a role for macrophages in vascular networking22,39. 
Macrophages were also present in the neuro-epithelium (Fig.1Dii). 
Chemokine and chemokine receptor expression on HBA cells.  Since chemokine 
receptor/ligand interactions are involved in inflammatory responses, we examined MacGreen 
HBA cells for the expression of Cx3cr1, Cxcr4, Cxcr2, Ccr7, Ccr5 and Ccr3. Flow cytometric 
analyses (Fig.1E, 1F) showed that >90% of GFP+ cells expressed Cx3cr1 with a high mean 
fluorescence intensity (MFI, Sup.Fig.1B) and >85% expressed Cxcr4, but at a much lower 
MFI. About 78% of GFP+ cells were Ccr3+ (MFIs intermediate to high). Neither Ccr7 nor 
Cxcr2 were expressed, and <20% of cells were Ccr5+. Hence, Cx3cr1, Cxcr4 and Ccr3 may 
be relevant to HBA macrophage signaling/function.   
To examine whether distinct HBA cells expressed the ligands for these receptors, 
hematopoietic (HC; CD41+ and/or CD45+), endothelial (EC; CD31+CD41-CD45-) and 
mesenchymal/other (MC; CD31-CD41-CD45-) cells were sorted (Fig.2A) and qRT-PCR 
performed (Fig.2B). Cx3cl1 expression was negligible in HCs and low in MCs, whereas 
expression in ECs was significantly higher than HCs. The expression of Cxcl12 (ligand of 
Cxcr4) was significantly higher in MCs than in either ECs or HCs. Ccl3 (ligand of Ccr1/Ccr5) 
was detected in both HCs and MCs, but not in ECs. Ccl11 (ligand of Ccr3) was weakly 
expressed in MCs. Together, these results suggest that the Cx3cr1/Cx3cl1 and/or 
Cxcr4/Cxcl12 signalling axes may be active in the HBA, particularly in recruitment of 
macrophages to head ECs and/or MCs.  
HBA macrophages and erythroid progenitors are quantitatively reduced in the 
absence of Cx3cr1.  Cx3cr1 may be involved in the recruitment of yolk sac macrophage 
progenitors to the brain where they give rise to tissue resident microglia 37,39. Given that >90% 
of HBA MacGreen macrophages express Cx3cr1 (Fig.1E), we tested whether deficiency of 
Cx3cr1 affects the percentage of macrophages in the HBA and whether HBA hematopoiesis 
is affected. The insertion of EGFP in the Cx3cr1 gene reports Cx3cr1 transcription while 
generating a null allele. No change in viable cell numbers in E10.5 Cx3cr1+/GFP (HT) and 
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Cx3cr1GFP/GFP (KO) HBA were found as compared wild type (WT) HBA (SupTable 4). 
However, macrophage percentages in HT (0.73%±0.02%) and KO (0.38%±0.02%) HBA 
were significantly reduced (0.15-fold and 0.57-fold respectively) as compared to WT 
(0.86%±0.07%) (Fig.3A, 3B). Also, the percentage of phenotypic HPCs (cKit+CD41low) was 
decreased significantly to 0.42%±0.02% in HT and 0.32%±0.04% in KO HBA, as compared 
to WT (0.49%±0.09%) (Fig.3A, 3D, Sup.Fig.2). Functional assessment of the E10.5 HBA, 
demonstrated a significant reduction in the total number of CFU-Cs in KO HBA as compared 
to WT (Fig.3F). Evaluation of specific colony types revealed statistically significant 
decreases in erythroid colony numbers in the E10.5 KO HBA as compared to WT. Despite 
decreased percentages of macrophages (Fig.3C) in the E11.5 HBA, phenotypic HPCs were 
not reduced (Fig.3E) and CFU-C numbers in the KO were similar to those in the WT HBA 
(Fig.3G). These data suggest that Cx3cr1 dependent macrophages play a role in 
erythropoiesis in the HBA prior to or at E10.5, but not thereafter, implicating differential 
and/or temporal regulation of HBA hematopoiesis.  
HBA macrophages promote the expansion and/or maturation of HBA EC-derived 
HPCs in OP9-DL1-B1 cocultures.  As we previously reported, hematopoietic cells are 
generated from ECs in the embryonic head5 and in vitro OP9-DL1 cocultures. To test the 
effect of head macrophages (MФ) on head EC-derived hematopoiesis, we sorted HBA ECs 
(CD31+CD41-CD45-) and HBA MФ (CD45+CD11b+F480+) (Sup.Fig.3A) and cocultured them 
on OP9-DL1-B1 (Bmp4-/-) stromal cells (Fig.4A). E10.5 HBA (VavCre transgenic) ECs and 
WT HBA MФ were used to validate the source of hematopoietic cells generated in the 
cultures. Following 7 days of OP9-DL1-B1 coculture, round semi-adherent clusters of 
hematopoietic cells were microscopically visible in the EC and EC+MФ (MIX) cell cultures 
(Fig.4B). MФ only cultures did not contain clusters, but 0.12±0.09x103 CD45+ cells remained 
of the 1x103 input MФ after 3 and 7 days of culture (Sup.Fig.3B). Whereas EC cultures 
contained 6.50±1.21x103 CD45+ cells, MIX cultures showed 1.7-fold more CD45+ cells 
(10.95±2.30x103) (Fig.4C) than the EC cultures, suggesting that MФ addition increases 
hematopoiesis.  
Sorted CD45+ cells from the cultures were plated into methylcellulose culture to test for 
progenitor activity. After 7 days of MIX coculture, a significant 3.4-fold increase in CFU-C 
number (561.3±138.2 CFU-C/ee) was found as compared to EC cocultures (166.0±52.92 
CFU-C/ee) (Fig.4D). We next analysed the DNA of individual CFU-C from the MIX cultures 
of Vav-Cre EC and WT CD45+CD11b+F4/80+ MФ to identify the source of the HPCs. Of the 
40 CFU-Cs examined for the Cre transgene by PCR, all were positive, indicating that they 
were EC-derived (Sup.Fig.3C). No CFU-C originated from the MФ. These data demonstrate 
that HBA MФ promote an increase in EC-derived HPCs in vitro.  
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HBA macrophage depletion influences HS/PC numbers.  Using the rationale that >95% 
of HBA MФ are Csf1r expressing (Fig.1B) and that Csf1r is not expressed by HSCs or some 
HPCs in the midgestation embryo 40,41 or as we found by 36% of HBA HPCs (Sup.Fig.4B), 
the Csf1r inhibitor BLZ945 was added to the MIX cultures to test whether MФ depletion 
affects HBA HPC numbers. Whereas the number of CD45+ hematopoietic cells showed little 
change between BLZ945-treated and vehicle-treated control MIX cultures (Fig.4E), the 
number of CFU-C was significantly reduced in the BLZ945-treated MIX cultures and was 
similar to EC-only cultures, as compared to the control MIX cultures (Fig.4F). These results 
suggest that the in vitro increase in HBA HPCs is dependent on MФ.  
To further examine HBA hematopoiesis in vivo in the absence of MФ, Csf1r-Cre mice were 
crossed with RosaDTA mice (lox-stop-lox-diphtheria toxin A). Normal Mendelian ratios of 
Csf1r-Cre:DTA and WT midgestation embryos were found (SupTable 5). The total viable 
HBA cell number was comparable between Csf1r-Cre:DTA and WT siblings (SupTable 6), 
and viable cell percentages similar in E9.5 to E11.5 HBA (Sup.Fig.4; Fig.5A). Whereas 
CD31+CD45- EC percentages were unaffected (Fig.5C) in the E9.5 to E11.5 Csf1r-Cre:DTA 
HBA and hematopoietic-related gene expression was not affected (E10.5; Sup.Fig.4E), 
MФ(CD45+CD11b+F480+) were almost completely absent (Fig.5B), indicating the specificity 
of targeted ablation. Interestingly, the percentage of phenotypic HCs (CD45+CD11b-F4/80-; 
excludes macrophages) was decreased in the E9.5 to E11.5 Csf1r-Cre:DTA HBA, compared 
with the WT siblings (Fig.5D).  CFU-C assays confirmed a decrease in functional HPC, with 
3.0±3.0 CFU-C per E9.5 Csf1r-Cre:DTA HBA as compared to 73.3±18.3 CFU-C per WT 
HBA. Similar decreases in CFU-Cs were found in the E10.5 and E11.5 Csf1r-Cre:DTA HBA 
(38.5±5.3, 18.0±9.9 per HBA, respectively) compared with control (155.0±47.7, 503±41.8 per 
HBA) (Fig.5E).  These results, together with the results of the coculture system suggest that 
macrophages have a positive influence on the expansion and/or maturation of HPCs in the 
HBA.  
In vivo transplantation assays were performed with cells from E11.5 Csf1r-Cre:DTA HBA to 
test whether macrophages are involved in HSC development. Whereas the peripheral blood 
donor cell chimerism in 3 of 8 mice injected with WT HBA cells was >5% at 4 weeks post-
transplantation and averaged 22.7±12.3% at 16 weeks post-transplantation, no recipients (0 
of 8; n=5) receiving Csf1r-Cre:DTA HBA  cells were donor cell-engrafted (Fig.5F). These 
data support a role for macrophages in HS/PC expansion and/or maturation in the HBA. 
Pro-inflammatory signalling molecules are expressed by HBA cells. Macrophages may 
function in the HBA through the local secretion of pro-inflammatory factors such as IL1 and 
TNFα, which have been shown by others to be involved in embryonic hematopoiesis11,28. To 
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examine pro-inflammatory factor expression in the HBA (MacGreen embryos), qRT-PCR 
was performed for IL1α, IL1β, TNFα and IL-6 on GFP+ cells (mostly macrophages, Fig.1B), 
other HBA cells (GFP-) and control OP9-DL1-B1 cells. IL1α, IL1β and TNFα were expressed 
exclusively by GFP+ cells, while IL-6 expression was restricted to OP9-DL1 cells (Fig.6A). 
Expression was also examined in EC (CD31+CD45-) and MФ (CD45+CD11B+F480+GFP+) 
(Fig.6B). IL1α, IL1β and TNFα expression was confirmed in MФ and only low/no expression 
in EC. If these pro-inflammatory factors are involved in the EHT process or hematopoietic 
growth, receptor expression would be expected on HBA EC or HC. According to the gating 
strategy in Fig.2A, MC (mesenchymal cells/other), ECs and HCs were sorted and tested for 
expression of IL1 receptors (IL1R1, IL1Rap, IL1R2) and TNFα receptors (TNFR1, TNFR2). 
All three HBA populations expressed IL1R1 and IL1Rap. IL1R2 was highly expressed in HCs, 
with very little/no expression in MCs and ECs. TNFR1 expression was 4.2-fold higher in ECs 
as compared to MCs and 2.2-fold higher than HCs. In contrast, TNFR2 was expressed 
highly in HCs (Fig.6C). These results showing expression of IL1R1, IL1Rap and TNFR1 on 
HBA ECs and TNFR2 on HCs suggest that they may respond to MФ-derived IL1β and TNFα.  
Supernatants from cocultures were tested for the presence of pro-inflammatory factors TNFα 
and IL1β. ELISA analysis showed quantitatively higher levels of TNFα in the MФ only 
(2511.0±668.9fg/ml) and MIX (2049.0±188.3fg/ml) cultures compared to EC 
(371.3±231.1fg/ml) cultures (Fig.7A). Only very low levels of IL1β protein were found in the 
three cultures (data not shown). Hence, macrophage-produced TNFmay induce HS/PC 
generation and/or maturation in the mouse HBA. 
Pro-inflammatory factor TNF addition to HBA EC cultures increases HPC numbers.  
To test whether TNFα could substitute for HBA MФ, TNFα was titrated into HBA EC cultures. 
After 7 days, CD45+ cell numbers were not significantly changed in 1ng/ml or 10ng/ml TNF-
supplemented cultures as compared to the no-TNF cultures, but were reduced in 50ng/ml 
TNFα cultures (Fig.7B). However, significant increases in CFU-C numbers (1073.0±225.9 
and 931.7±67.6 respectively) were found in cultures with 1ng/ml or 10ng/ml TNFα, 
compared to no-TNFα cultures (557.6±68.2). 50ng/ml TNFα cultures yielded similar CFU-C 
to cultures without TNFα(Fig.7C).  
To validate the effect of TNF we added TNF neutralizing antibody (nAb) to EC and MIX 
culturesCD45+ cell and CFU-C numbers did not change in the EC cultures in the presence 
of the nAb (Fig7D, 7E). In contrast, addition of nAb to MIX cultures showed a significant 
reduction in CFU-C numbers (659.0±80.6), as compared to MIX (933.9±62.1) and EC + 
TNF (931.7±67.6) control cultures (Fig.7E). These results suggest that TNFα-secreting MФ 
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promote expansion and/or maturation of HPCs (mostly GM progenitors) derived from HBA 
ECs.  
 
Discussion 
Our identification of a novel role for macrophages in hematopoiesis in the developing HBA 
now adds to the known roles of macrophages in the embryonic head, such as vascular 
networking by tip fusion of endothelial cells22 and neuronal interactions and patterning42,43. 
Interestingly Cx3cr1/Cx3cl1 axis is involved all these developmental processes. 
Macrophages influence the expansion and/or maturation of HBA HS/PCs, and likely regulate 
this process through production of TNFα. Although some pro-inflammatory molecules were 
shown previously to affect the emergence of HS/PCs in the aorta region of zebrafish and 
mouse embryos11,15, this is the first demonstration that macrophages are important cellular 
regulators of embryonic head hematopoiesis. As macrophages are involved in neuronal 
patterning of the embryonic brain21, our results from early hematopoietic developmental 
stages may have biomedical relevance for neuropathologies during later life stages.  
Macrophages in the embryonic HBA regulate hematopoiesis in vivo.  As well as 
expressing macrophage markers CD11b, F4/80 and CD45, all midgestation HBA 
macrophages express the Csf1r-GFP reporter. Csf1r-expressing cells were found in close 
proximity to the CD31+ brain vasculature and by flow cytometry were found to express high 
levels of the Cx3cr1, Cxcr4 and Ccr3 chemokine receptors. Interestingly, HBA endothelial 
cells express Cx3cl1, the ligand for Cx3cr1.  
It has been shown that emigration of yolk sac-derived macrophages to the embryonic brain 
18,19 and to the AGM 16 is dependent on the Cx3cr1/Cx3cl1 signaling axis. Hematopoietic 
cells in the aorta during the time of endothelial-to-hematopoietic transition are 
decreased/absent in the absence of Cx3cr1, and AGM HPC numbers and HSC in vivo 
repopulating activity are decreased in Cx3cr1 null embryos 16 . Similarly, we found that HPC 
numbers in the HBA of Cx3cr1 null embryos were significantly reduced. This is likely to be a 
consequence of decreased macrophage emigration to this region and is supported by the 
fact that macrophage (CD45+CD11b+F4/80+) percentages were significantly (50%) reduced 
and percentages of progenitor cells (cKit+CD41low) were also significantly reduced in the 
Cx3cr1 null HBA.  
We also examined the role of macrophages in HBA hematopoiesis by Cre-Lox targeting 
DTA-mediated ablation to Csf1r+ macrophages. HPC numbers in the Csf1r-DTA HBA were 
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significantly reduced as compared to numbers in WT littermate HBAs. Moreover, no 
transplantable HSCs were found in Csf1r-DTA HBAs. It is important to note that there was a 
complete absence of CD45+CD11b+F4/80+ macrophages in the Csf1r-DTA HBA, but viable 
cells and CD31+CD45- EC percentages were largely unaffected.  
Since Csf1r is expressed on multilineage (B, T and myeloid) progenitors in the embryo it has 
been suggested that this receptor plays a role in early hematopoiesis 44,45. Others have 
recently reported that Csf1r is expressed by and regulates myeloid-primed B-lymphoid 
progenitors in the mouse fetal liver 46. Single cell RNAsequencing of highly enriched HS/PCs 
from mouse embryonic and fetal stages reveal some low Csf1r expression on these cells47, 
yet Csf1r cell tracing and other studies suggest that Csfr1 is not expressed by HSCs 16,41. 
Thus, it is unclear in the HBA, whether cells other than macrophages express Csf1r. Our 
analysis of sorted MacGreen HBA cells revealed that HPCs were distributed in the high, 
intermediate and negative expressing fractions (Sup.Fig.4A) and thus, has implications for 
the use of the in vivo Csf1r targeted DTA ablation model. Within E10.5 HBA, 36% of HPC 
are Csfr1 negative, 28% are intermediate-expressing and 36% are high-expressing. If DTA 
is directly ablating the high and intermediate expressing HPCs, we would expect to find a 64% 
decrease in the number of CFU-C/HBA. However, a 78% decrease in CFU-C/HBA was 
found (Fig.5E), leaving open the possibility that some Csf1r negative HPCs are affected by 
the absence of macrophages. Further studies are needed to address this.     
As compared to DTA-mediated macrophage ablation, which resulted in large reductions in 
CFU-C numbers/HBA, deficiency of Cx3cr1 had a mild effect, reducing CFU-C numbers by 
only 10%. The differences are likely due the fact that in addition to Cx3cr1/Cx3cl1, several 
other chemokines/ligands are playing roles in recruiting macrophages/progenitors to the 
HBA. Indeed, not only is Cx3cr1 and its ligand expressed in macrophages and ECs 
respectively, but Cxcr4 and its ligand Cxcl12 respectively are expressed in macrophages 
and MCs of embryonic head. The Cxcr4/Cxcl12 axis maintains the HSC pool in the adult 
bone marrow, and hence it may play an HS/PC maintenance role in the HBA.  
Macrophages promote increases in HPC numbers from HBA endothelial cells in vitro.  
Vascular structures in the embryonic head are complex. Unlike the aorta, in which 
hematopoietic cell clusters have been found in close association with the vascular 
endothelium, only single hematopoietic cells have been found in association with the 
embryonic head vasculature6,48. Three-dimensional composite images of the whole Csf1r-
GFP embryonic head, show a close association of GFP+ macrophages with CD31+CD45- 
ECs, suggesting an influence of macrophages in the HBA in vivo. We used an in vitro 
coculture system to test for the effects of macrophages on hematopoietic cells and HPCs 
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arising from HBA ECs. Like aortic ECs, cultures of HBA ECs show that the head vasculature 
produces HS/PC. A significant 3-fold increase in HPCs in MФ+EC (MIX) cocultures was 
found, as compared to ECs alone. When a Csf1r inhibitor was added, it blocked the 
promotion of HPC expansion. This could be due to the direct effects of the inhibitor on 
macrophages or may be due to direct effects of the inhibitor on Csfr1 expressing HPCs. 
Interestingly, the same number of CFU-C/HBA was found as those produced by the EC-only 
cultures, thus the HBA contains some Csf1r independent HPC. The interaction of HBA 
macrophages with HBA EC may, in addition to increasing HPC numbers, influence EC 
hematopoietic fate induction. We have attempted to examine this issue in the OP9-DL1-B1 
MIX and EC cultures. Preliminary results indicate that the number of hematopoietic-like 
clusters generated after 3 or 7 days of MIX cultures increases by a factor of 2 compared to 
the EC cultures (the number of cells per cluster does not change). Continuous vital imaging 
of EC and HC at the single cell level in MIX cultures is necessary to resolve this issue.    
Actions of pro-inflammatory factors on HBA hematopoiesis.  Within the cells of the HBA, 
we found that the pro-inflammatory factor TNFα was most highly and specifically expressed 
by macrophages. HBA ECs express their cognate receptors. Supplementation of HBA EC 
cultures with TNFα resulted in more HPCs: HPC numbers were increased to the same 
degree as when macrophages were added to the culture. Moreover, a TNFα blocking 
antibody when added to the MIX cocultures, reduced HPC numbers to those found in EC 
only cocultures. Our data is consistent with a previous report in which TLR stimulations in 
embryos resulted in the secretion of cytokines including TNFα, from macrophages49. Other 
groups have shown that neutrophil-derived TNFα in zebrafish embryos is required for HS/PC 
specification11, and that TNFα in adult mouse bone marrow granulocytes promotes vascular 
and hematopoietic regeneration50. However, the role for the TNF signalling pathway in HSC 
maintenance is controversial. In a TNF loss-of-function in vivo model, one group showed that 
TNF plays a stimulatory function on HSC maintenance51. In contrast, another group showed 
that TNF is a suppressor of normal HSC activity in vitro and in vivo52-55. In our coculture 
system, the observed positive influence of TNFα on CD45+ cell numbers is concentration 
dependent: Low and intermediate concentrations of TNF increased CFU-C number/HBA, 
whereas a high concentration showed the same CFU-C number/HBA as in the absence of 
TNFThus, the concentration of active TNFα may explain the conflicting results in the 
literature. In the HBA, it is likely that TNFα exerts its positive influence on the HPC in vitro 
through factor concentration gradients elicited through the direct interaction with or proximity 
of macrophages. 
14 
 
Along with IL1β which we have shown here is expressed by HBA macrophages, factors such 
as IFNγ and prostaglandin E2 that have been shown to regulate HSC production of zebrafish 
and mouse AGM HSCs15,56,57 would be interesting to examine in the HBA for effects on 
endothelial to hematopoietic transition and HPC function. Together with transcriptome 
profiling of HBA macrophages, it may be possible to identify the combination and balance of 
different factors regulating hematopoiesis at different sites of embryonic development. 
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Figure Legends 
Figure 1. Characterization of macrophages in E9.5 to E11.5 MacGreen HBA. (A) 
Schematic diagram of dissected hindbrain-branchial arch (HBA) region on the mouse 
embryonic head. The region includes the 1st and 2nd branchial arches. (B) Flow cytometric 
profile for E10.5 MacGreen HBA cells showing that all GFP+ (high-expressing) cells are 
CD45+CD11b+F4/80+Gr1- macrophages. Percentages shown in gated areas. FSC=forward 
scatter. (C) Percentages of MacGreen GFP+ cells in E9.5, E10.5 and E11.5 HBA (n≥3). 
*p=0.016, ***p<0.001. (D) Three-dimensional whole-mount images of an immunostained 
MacGreen E10.5 head (34 somite pairs (sp)), with boxed areas enlarged in right panels. 
Anti-GFP (green) and anti-CD31 (magenta) antibody staining shows localization of 
macrophages surrounding the CD31+ vasculature. CA=carotid artery, V=brain ventricle, 
NE=neuro-epithelium. Bar=10 μm. (E) Representative flow cytometric data showing mean 
fluorescence intensity (MFI) and percentage of GFP+ macrophages and GFP- cells 
expressing chemokine receptors in the E10.5 (32-39 sp) MacGreen HBA. Dotted line=FMO, 
dashed line=GFP – cells and black line with grey filled=GFP+ cells. (F) Bar graphs showing 
percentages of chemokine receptor-expressing cells in the GFP+ fraction. n=4 for Cx3cr1, 
Ccr7, Ccr5, Ccr3 and n=3 for Cxcr4, Cxcr2.  
 
Figure 2. HBA cell subset-specific expression of chemokines at E10.5. (A) Flow 
cytometric sorting strategy for enrichment of mesenchymal/other cells (MC; CD31-CD41-
CD45-), endothelial cells (EC: CD31+CD41-CD45-) and hematopoietic cells (HC; CD41+ 
and/or CD45+). (B) Relative expression of mRNA for chemokine genes Cx3cl1, Cxcl12, Ccl3 
and Ccl11 as normalized to actin in E10.5 HBA sorted MC, EC and HC. SEM is shown. n=5, 
*p<0.05, **p<0.01.  
Figure 3. Cx3cr1 deficiency leads to the reduction of hematopoietic progenitors in 
E10.5 HBA, but not in E11.5 HBA. (A) Representative flow cytometric data and gated areas 
showing percentages of CD45+ hematopoietic cells, cKit+CD41low hematopoietic progenitor 
cells, GFP+CD45+ cells and GFP+CD45+CD11b+F4/80+ macrophages in the HBA of 
Cx3cr1+/+ (wild type=WT), Cx3cr1+/GFP (heterozygous mutants=HT) and Cx3cr1GFP/GFP 
(knockout=KO) E10.5 littermates. The percentage of CD45+CD11b+F4/80+ macrophages in 
the WT, HT and KO HBA of (B) E10.5 (31-39 sp) and (C) E11.5 (42-48 sp) embryos. Each 
square represents a single HBA, n=4, **p<0.01, ***p<0.001. The percentage of cKit+CD41low 
progenitor cells in WT, HT and KO HBA of (D) E10.5 and (E) E11.5 littermates. n=4, 
*p=0.026, **p=0.006. Methylcellulose culture data showing the number of CFU-Cs per 1 
embryo equivalent (ee) of E10.5 (F) and E11.5 (G) WT, HT and KO HBA cells. n=3, 
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*p=0.047.  Numbers of each colony type are indicated by bar color. CFU-C=colony forming 
unit-cell; GEMM= granulocyte, erythroid, macrophage, megakaryocyte; GM=granulocyte, 
macrophage; M=macrophage; G=granulocyte; E=erythroid. 
Figure 4. HBA macrophages increase number of HBA EC-derived HPCs. (A) Schematic 
diagram of the coculture system, with a monolayer of OP9-DL1-B1 cells overlaid with HBA 
endothelial cells (EC), HBA macrophages (MФ) or EC+ MФ (MIX). One embryo equivalent of 
HBA ECs (CD31+CD41-CD45-) and/or 1,000 HBA MФ (CD45+CD11b+F480+) were added to 
each coculture well. After 7 days, non-adherent cells were harvested, FACS sorted and 
plated in methylcellulose to quantitate hematopoietic colonies (CFU-C). The genotype of 
each colony was determined by Cre PCR. (B) Bright field microscopic images show the 
round morphology and density of hematopoietic cells after 7 days of OP9-DL1-B1 culture of 
EC, MФ or MIX. The number of (C) CD45+ cells and (D) CFU-Cs per ee of E10.5 (31-35 sp) 
HBA cells after 7 days of OP9-DL1-B1 culture of EC, MФ or MIX. n=4, *p<0.05. The number 
of (E) CD45+ cells and (F) CFU-Cs per ee of E10.5 HBA from OP9-DL1-B1 culture of EC 
and MIX with or without Csf1r inhibitor BLZ945 (6.7nM). BLZ945 (BLZ) is diluted in DMSO. 
EC& and MIX& have the DMSO& diluent added as a vehicle control. SEM is shown. n=3, 
*p<0.05. ee=embryo equivalent. Colony types indicated by color bars.  
Figure 5. Hematopoietic stem/progenitor cells are reduced in the E9.5 to E11.5 HBA in 
Csf1r-directed DTA depletion. Percentages of (A) viable HBA cells as determined by 
Hoescht dye exclusion, (B) CD45+F480+CD11b+ macrophages, (C) CD31+CD45- endothelial 
cells and (D) CD45+F4/80-CD11b- hematopoietic cells from E9.5 to E11.5 wild type (WT) and 
Csf1r-Cre+/DTA (Cre+/DTA) littermates in FACS analysis. Each dot or square represents one WT 
or Cre+/DTA embryo. SEM is shown. n=3, *p<0.05, ***p<0.001. MФ=macrophages; 
EC=endothelial cells; HC=hematopoietic cells. (E) CFU-C per embryo equivalent (ee) of 
HBA cells in E9.5, 10.5 and 11.5 WT and Cre+/DTA littermates. Colony type is indicated by 
color bars. E9.5 n=2, E10.5 n=3, E11.5 n=3, *p<0.05, ***p<0.001. (F) Percentage of donor-
cell (Ly5.2) chimerism in the peripheral blood of irradiated (Ly5.1) recipients injected with WT 
or Cre+/DTA E11.5 (44-48 sp) HBA cells as determined by Ly5.1/Ly5.2 FACS analysis. Eight 
recipients received WT (1-3 ee) and 8 recipients received Cre+/DTA (1-3) HBA cells. Dots and 
squares indicate individual recipients of WT or Cre+/DTA cells respectively that were examined 
at 4 and 16 weeks (W) post-transplantation. n=5. 
Figure 6. Genes of proinflammatory pathways are expressed in HBA cells. (A) Relative 
mRNA expression of IL1α, IL1β TNFα and IL-6 normalized to actin in GFP+ (G+) and GFP- 
(G-) cells in the E10.5 MacGreen HBA as determined by qRT-PCR. OP9-DL1-B1 (DL1) is the 
negative control. n=3, *p<0.05. (B) Relative mRNA expression of IL1α, IL1β TNFα and IL-6 
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as normalized to actin in macrophages (M, CD45+CD11b+F4/80+Gr1-), endothelial cells (EC, 
CD31+CD45-) in the E10.5 HBA as determined by qRT-PCR. OP9-DL1-B1 (DL1) is the 
negative control. n=4, *p<0.05, **p<0.01, ****p<0.0001. (C) Fold-change in the relative 
mRNA expression of IL1 and TNF receptor genes (IL1R1, IL1Rap, IL1R2, TNFR1, TNFR2) 
in E10.5 HBA endothelial cells (EC) and hematopoietic cells (HC) as compared to 
mesenchymal/other cells (MC). IL1R1, IL1Rap, IL1R2, TNFR2 n=3 and TNFR1 n=4, *p<0.05.  
Figure 7. Pro-inflammatory factors are involved in HBA hematopoietic cell output.  (A) 
Concentration (fg/ml) of TNFα protein in the supernatant of OP9-DL1-B1 cultures containing 
E10.5 (34-39 sp) HBA EC, MФ or MIX (EC+MФ), as determined by FCAP assay. n=3, 
*p=0.039, **p=0.005. Number of (B) CD45+ cells and (C) CFU-C number per one embryo 
equivalent (ee) of HBA cells in EC cultures supplemented with different TNFα concentrations. 
n=4, Number of (D) CD45+ cells and (E) CFU-C/ee of E10.5 HBA cells in the OP9-DL1-B1 
cocultures containing EC, EC+TNFα nAb (neutralizing antibody 0.4μg/ml), EC+TNFα (10 
ng/ml), MIX, MIX+TNFα neutralizing Ab (0.4μg/ml). n=4. Colony types are indicated by color 
bars. *p<0.05, **p<0.01, ***p<0.001.  
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Supplemental Figures and Legends 
 
 
Supplemental Figure 1. Characterization of macrophages in E10.5 MacGreen HBA. (A) 
Flow cytometric profiles for E10.5 MacGreen HBA cells showing that all 
CD45+CD11b+F4/80+Gr1- macrophages cells are GFP+. Percentages shown in gated areas. 
FSC=forward scatter. (B) The Geometric Mean Fluorescence of chemokine receptors in the 
GFP+ fractions of E10.5 (32-39 sp) MacGreen HBA. n=4 for Cx3cr1, Ccr3, Ccr5, Ccr7 and 
n=3 for Cxcr4 and Cxcr2. Related to Figure 1. 
 
 
 
 
Supplemental Figure 2. Fluorescence minus one (FMO) controls and erthroid 
progenitor quantitation for the midgestation HBA. (A) Flow cytometric profiles showing 
gating for cKit and CD41 expressing cells. (B) CFU-E and BFU-E numbers per one embryo 
equivalent (ee) E10.5 HBA cells isolated from WT (wild type; Cx3cr1+/+), HT (heterozygous; 
Cx3cr1+/GFP) and KO (knockout; Cx3cr1GFP/GFP) embryos. CFU-E=colony forming unit-
erythroid; BFU-E=burst forming unit-erythroid. n=3, *p=0.05, p**=0.01. Related to Figure 3.   
 
 
 
Supplemental Figure 3. Macrophages are involved in HBA hematopoietic cell 
formation in vitro. (A) Representative FACS data shows gating strategy of sorted 
endothelial cells (EC; CD41-CD45-CD31+) and macrophages (Mφ; CD45+F4/80+CD11b+) 
from E10.5 HBA. FMO CD31 as control for gating CD31. (B) Number of CD45+ cells per 
embryo equivalent (ee) of HBA during culture. n=3. (C) Representative PCR genotyping data 
from individually harvested CFU-C following OP9-DL1-B1 culture. Endothelial cells used for 
culture carry the Cre transgene. Macrophages are transgene negative (WT; wild type). All 
CFU-Cs obtained from EC alone or EC+ Mφ (MIX) cultures are derived from endothelial 
cells. Cre HBA=positive control, GFP HBA=negative control, DL1=OP9-DL1-B1(Bmp4 
deletion). Related to Figure 4. 
 
 
 
  
 
 
 
Supplemental Figure 4. HBA macrophages and some progenitors are MacGreen 
expressing and are reduced in the E10.5 Csf1rCre/DTA HBA. (A) Flow cytometric profile 
showing gates for GFP HI- (high), INT- (intermediate), and NEG-(negative) expressing HBA 
cells from E10.5 MacGreen embryos. (B) CFU-C number per one embryo equivalent of 
GFPHI, GFPINT and GFPNEG sorted E10.5 HBA cells from E10.5 MacGreen embryos. Number 
of individual colony types are indicated. CFU-C=colony forming unit-cell; GEMM= 
granulocyte, erythroid, macrophage, megakaryocyte; GM=granulocyte, macrophage; 
M=macrophage; G=granulocyte; E=erythroid. (C) Relative mRNA expression of Csf1r in 
GFPHI, GFPINT and GFPNEG sorted E10.5 HBA cells from E10.5 MacGreen embryos as 
determined by qRT-PCR. Actin was used as the normalization control. SEM is shown. n=3, 
*p<0.05. (D) Representative flow cytometric data showing gating strategy of E10.5 WT (wild 
type) and Csf1r-Cre+/DTA HBA cells. (E) Relative mRNA expression of Runx1 and Gata2 in 
endothelial cells of WT (wild type) and Csf1r-Cre+/DTA E10.5 HBA as determined by qRT-
PCR. Actin was used as the normalization control. Related to Figure 5.  
Supplemental Tables 
 
Supplemental Table 1. PCR primer sequences for genotyping 
Cx3cr1 Wild type-Forward 5’-GTCTTCACGTTCGGTCTGGT-3’ 
Cx3cr1 Mutant-Forward 5’-CTCCCCCTGAACCTGAAAC-3’ 
Cx3cr1 Common-Reverse 5’-CCCAGACACTCGTTGTCCTT-3’ 
  
Cxr1r-Cre-Forward 5’-CTGGCTGTGAAGACCATC-3’ 
Csf1r-Cre-Reverse 5’-CAGGGCCTTCTCCACACCAGC-3’ 
  
RosaDTA-Forward 5’-GACGCTGCGGGATACTCTGT-3’ 
RosaDTA-Reverse 5’-CTGAGCACTACACGCGAAGC-3’ 
 
 
 
Supplemental Table 2. Antibody list 
Antibody Clone No. company 
CD31 AF647 MEC13.3 BD Bioscience 
CD45 PE 30-F11 BD Bioscience 
CD41 eFluor450 MWReg30 eBioscience 
CD11b BV605 M1/70 eBioscience 
F4/80 PECy5 BM8 eBioscience 
Cx3cr1 BV650 SA011E11 Biolegend 
Cxcr4 PE Dazzle594 L276F12 Biolegend 
Ccr3 PECy7 J073E5 Biolegend 
Ccr5 PE HM-CCR5 Biolegend 
Ccr7 BV421 4B12 Biolegend 
Cxcr2 PerCP Cy5.5 SA045E1 Biolegend 
CD45.1 APC A20 BD Bioscience 
CD45.2 PE 104 BD Bioscience 
CD31 Biotin MEC13.3 BD Bioscience 
GFP 598 MBL 
 
  
 Supplemental Table 3. Primer sequences for qRT-PCR 
 
 
 
 
Supplemental Table 4. Cell number in WT, Cx3crGFP/+ (HT), Cx3cr1GFP/GFP (KO) HBAs 
Embryo 
stage 
Genotype Cell Number 
(mean±SEM, X105) 
Number  of 
experiments 
E10.5 WT 4.02±0.27 3 
HT 4.78±0.08 3 
KO 4.11±0.14 4 
E11.5 WT 13.45±0.81 3 
HT 13.35±0.65 3 
KO 14.90±0.7 3 
 
 
IL1a-Forward 5’- CGAAGACTACAGTTCTGCCATT -3’ 
IL1a-Reverse 5’- GACGTTTCAGAGGTTCTCAGAG -3’ 
IL1β-Forward 5’- TGGACCTTCCAGGATGAGGACA -3’ 
IL1β- Reverse 5’- GTTCATCTCGGAGCCTGTAGTG -3’ 
TNFa -Forward 5’- GGTGCCTATGTCTCAGCCTCTT -3’ 
TNFa - Reverse 5’- GCCATAGAACTGATGAGAGGGAG -3’ 
IL6 -Forward 5’- TAGTCCTTCCTACCCCAATTTCC -3’ 
IL6 - Reverse 5’- TTGGTCCTTAGCCACTCCTTC -3’ 
IL1R1-Forward 5’- CACTGGACCTCGGGTAACTC -3’ 
IL1R1- Reverse 5’- TTGGTCCTTAGCCACTCCTTC -3’ 
IL1Rap -Forward 5’- TGCCTGGGGGAATTGTCAC -3’ 
IL1Rap - Reverse 5’- CTTAGCCCGCTTCAGCTCTTT -3’ 
IL1R2-Forward 5’- GTTTCTGCTTTCACCACTCCA -3’ 
IL1R2- Reverse 5’- GAGTCCAATTTACTCCAGGTCAG -3’ 
Tnfrsf1a- Forward 5’- CCGGGAGAAGAGGGATAGCTT -3’ 
Tnfrsf1a- Reverse 5’- TCGGACAGTCACTCACCAAGT -3’ 
Tnfrsf1b- Forward 5’- ACACCCTACAAACCGGAACC -3’ 
Tnfrsf1b- Reverse 5’- AGCCTTCCTGTCATAGTATTCCT -3’ 
Cx3cl1-Forward 5’- CCCAGACAGAAGTCATAGCCA -3’ 
Cx3cl1- Reverse 5’- ACACATCCAGACACCGTTGG -3’ 
Cxcl12-Forward 5’- AGAGCCCTAGACCCATTTCCT -3’ 
Cxcl12- Reverse 5’- CATTCTTCAGGGTGGCTATGA -3’ 
Ccl3-Forward 5’- TTCTCTGTACCATGACACTCTGC -3’ 
Ccl3- Reverse 5’- CGTGGAATCTTCCGGCTGTAG -3’ 
Ccl7-Forward 5’- GCTGCTTTCAGCATCCAAGTG -3’ 
Ccl7- Reverse 5’- CCAGGGACACCGACTACTG -3’ 
β Actin- Forward 5’- CACCACACCTTCTACAATGAG -3’ 
β Actin- Reverse 5’- GACCCAGATCATGTTTGAGAC -3’ 
 
Supplemental Table 5. Numbers of WT and Csf1r-Cre+/DTA embryos 
Embryo 
stage 
Genotype Number of 
embryos 
Number of 
experiments 
Csf1r-Cre+/DTA embryos: 
total embryos 
E10.5 WT 39 7 12:51=0.24 
Csf1r-Cre+/DTA 12 
E11.5 WT 88 9 34:122=0.28 
Csf1r-Cre+/DTA 34 
 
 
 
Supplemental Table 6. Numbers of cells obtained from WT and Csf1r-Cre+/DTA HBAs 
Embryo  
stage 
Genotype Cell Number 
(mean±sem, x105) 
Number of 
experiments 
E9.5 WT 1.2±0.13 6 
Csf1r-Cre+/DTA 1.0±0.07 5 
E10.5 WT 5.0±0.67 4 
Csf1r-Cre+/DTA 4.98±0.51 4 
E11.5 WT 13.23±2.30 4 
Csf1r-Cre+/DTA 11.48±1.15 5 
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